Thursday, July 05, 2018 11:31:39 AM
Each Convertible Debenture issued pursuant to this first tranche will have a maturity date of July 5, 2020 and be convertible into common shares of ZeU (each a “ZeU Share”) at a price of $1.00 (the “Conversion Price”).
There shall be no interest payable on the Principal Amount if ZeU effects a transaction pursuant to which it will become a “reporting issuer” under applicable Canadian Securities Laws and the ZeU Shares or the common shares of any resulting issuer would be listed and posted for trading on an recognized exchange, which may include, without limitation, an initial public offering, a reverse take-over or a merger with existing a reporting issuer (a “Liquidity Event”) on or before January 31, 2019 (the “Liquidity Event Deadline”). If there is not a Liquidity Event on or before the Liquidity Event Deadline then interest shall be deemed to accrue from and including July 5, 2018.
Upon the occurrence of a Liquidity Event, ZeU will be entitled to require the holders of Convertible Debenture to convert up to 25% of the Principal Amount outstanding, together with any accrued and unpaid interest owing thereon, into ZeU Shares at the Conversion Price.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM